

Welcome in Bioclarma
Innovation in Molecular Diagnostics

A decade of innovation in service of health.
For over a decade, Bioclarma has established itself as a reference point in the production of in vitro medical diagnostic devices, providing reliable and cutting-edge solutions for hospital diagnostic laboratories in Italy and around the world.
Our company is committed to providing high-quality diagnostic tools to address the challenges of diagnosis and monitoring in onco-hematological diseases.
Advanced tools
for the detection of Molecular Markers
in Leukemias
Our kits are designed for the diagnosis and monitoring of leukemias caused by the BCR/ABL fusion gene resulting from the t(9;22) translocation (Philadelphia Chromosome) and are capable of detecting and quantifying the following variants:
major P210, minor P190, micro P230, and the rare b3a3/b2a3, e1a3, nano (e6a2/e6a3).
Additionally, we offer solutions for other relevant genetic translocations such as:
PML/RARa t(15;17), AML1-ETO t(8;21), CBFB/MYH11 t(16;16), and TEL-AML1 t(12;21).
In addition to kits for genetic translocations, we offer a product line for the detection of coagulation factor defects and for COVID-19 diagnosis.
Additionally, Bioclarma offers a product line for the diagnosis of hereditary thrombophilia associated with polymorphisms in the Factor II (Prothrombin), Factor V, and Methylenetetrahydrofolate Reductase (MTHFR) genes, utilizing a direct method that does not require DNA purification.
Regarding COVID-19, our company produces a qualitative and quantitative assay that can be used on 96- or 384-reaction platforms, and can be performed on respiratory samples without the need for prior viral RNA extraction.
Analysis and on-demand services.
We offer a wide range of on-demand services, including:
- Luminex Analysis
- Proteomic Analysis
- Molecular Biology Analysis
To address the requirements of research laboratories dedicated to the discovery and development of cutting-edge medical therapies.

Join us in our commitment to excellence in medical diagnostics.

Davide BARBERIO
CEO

Salvatore TACCHETTI
Sales Manager

Rosalia BIONDI
Accounting and Administration

Moitza PRINCIPE
Quality and Regulatory Affairs Manager

Giorgia MANDILI
RD Manager and Services

Michele CUGUSI
Researcher

Giorgia GUADAGNIN
Quality Manager

Giulia MURA
Researcher

Amedeo MORACA
Research Collaborator
